Aigen Investment Management LP Sells 2,575 Shares of Cutera, Inc. (NASDAQ:CUTR)

Aigen Investment Management LP lessened its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 23.0% in the second quarter, HoldingsChannel.com reports. The firm owned 8,606 shares of the medical device company’s stock after selling 2,575 shares during the quarter. Aigen Investment Management LP’s holdings in Cutera were worth $422,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Advisor Group Holdings Inc. lifted its holdings in shares of Cutera by 629.0% in the 2nd quarter. Advisor Group Holdings Inc. now owns 729 shares of the medical device company’s stock worth $36,000 after purchasing an additional 629 shares in the last quarter. O Shaughnessy Asset Management LLC bought a new position in shares of Cutera in the 2nd quarter worth $44,000. US Bancorp DE lifted its stake in Cutera by 45.8% during the 1st quarter. US Bancorp DE now owns 1,592 shares of the medical device company’s stock valued at $48,000 after acquiring an additional 500 shares in the last quarter. Teachers Retirement System of The State of Kentucky lifted its stake in Cutera by 521.0% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 3,099 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 2,600 shares in the last quarter. Finally, Altshuler Shaham Ltd lifted its stake in Cutera by 138.7% during the 1st quarter. Altshuler Shaham Ltd now owns 3,808 shares of the medical device company’s stock valued at $114,000 after acquiring an additional 2,213 shares in the last quarter.

Several equities analysts have weighed in on CUTR shares. Zacks Investment Research upgraded Cutera from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a research note on Wednesday, August 11th. Piper Sandler lifted their target price on Cutera from $42.00 to $65.00 and gave the stock an “overweight” rating in a research note on Thursday, August 5th. They noted that the move was a valuation call. TheStreet upgraded Cutera from a “d” rating to a “c+” rating in a research note on Thursday, August 5th. Finally, Cantor Fitzgerald lifted their target price on Cutera from $55.00 to $60.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 13th.

Shares of CUTR opened at $49.26 on Wednesday. The business has a 50-day moving average of $49.79 and a 200 day moving average of $40.70. Cutera, Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $60.35. The firm has a market cap of $883.82 million, a P/E ratio of 136.84 and a beta of 1.63. The company has a debt-to-equity ratio of 2.51, a quick ratio of 3.38 and a current ratio of 3.95.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Wednesday, August 4th. The medical device company reported $0.39 earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.49. Cutera had a return on equity of 14.36% and a net margin of 3.71%. The company had revenue of $58.59 million during the quarter, compared to analyst estimates of $50.15 million. As a group, research analysts predict that Cutera, Inc. will post 0.17 earnings per share for the current fiscal year.

In related news, Director Joseph E. Whitters bought 1,500 shares of Cutera stock in a transaction on Monday, August 9th. The stock was acquired at an average price of $53.89 per share, with a total value of $80,835.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director J Daniel Plants bought 1,000 shares of Cutera stock in a transaction on Friday, August 13th. The shares were bought at an average cost of $49.99 per share, with a total value of $49,990.00. Following the acquisition, the director now directly owns 28,105 shares in the company, valued at $1,404,968.95. The disclosure for this purchase can be found here. In the last three months, insiders purchased 3,500 shares of company stock valued at $178,815. 2.10% of the stock is currently owned by insiders.

Cutera Profile

Cutera, Inc engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo.

Further Reading: How dollar cost averaging works

Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.